Skip to main content
. Author manuscript; available in PMC: 2018 Jul 15.
Published in final edited form as: Clin Cancer Res. 2017 Feb 13;23(14):3575–3584. doi: 10.1158/1078-0432.CCR-16-1369

Figure 4. Progression-free and Overall Survival by PD-L1 Expression.

Figure 4

Kaplan-Meier estimates of progression-free (A) and overall survival (B) in the subgroup of patients with peripheral blood analysis divided by expression of PD-L1 on circulating monocytes (n=32). Vertical lines indicate time points at which patients were censored.